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Background
Colorectal cancer (CRC) is a major cause of cancer-related
mortality worldwide. Currently, tumor-node-metastasis
staging system still remains the gold standard for prog-
nosis of CRC patients, but it is no longer sufficient.
Among the most important molecules involved in colorec-
tal tumor growth, cell proliferation and progression are
adhesive molecules such as CD44 and E-cadherin (EC).
The aim of this study was to evaluete the expression of
CD44 standard protein and EC in correlation with Ki-67
proliferative index and some other clinicopathological
prognostic variables in patients with CRC.
Methods
Eighty one patients with CRC were studied by hematoxy-
lin-eosin stain on formalin fixed paraffin embedded tumor
tissue obtained by radical surgery. Ki-67, EC and CD44
were analysed by immunohistochemistry, using labeled-
streptavidin-biotin (LSAB) method with anti Ki-67, anti-
EC and anti-CD44 standard monoclonal antibodies in
optimal concentrations. of immunohistochemical analysis
were evaluated semi-quantitatively by determination of
percent of CD44 positive cells and presence/abssence of
EC positive cells. Ki-67 proliferative index was estimated
as percent of positive cells by counting 500 tumor cells
were analysed using statistical tests, adopting a significance
level of 5%.
Results
36 of the 81 analyzed patients were in stadium C and D
according Dukes original classification, 24 in stadium B
and 21 in stadium A. Increased CD44 expression was
present in 87.7% of patients with disease progression
versus 12.3% of patients without progression (p≤0.05).
Overall survival in patients with high CD44 expression
was 23.5 months versus 35 months in the low CD44
expression group (p≤0.05). Monitoring of desease pro-
gression within two years period and overall survival
showed a statistically significant difference between the
group of patients with heterogenous or loss of EC expres-
sion and group with regular EC expression (78.3% and 21
months versus 47.6% and 46 months respectively). How-
ever, there were no significant differences in the Ki-67
proliferative index between the group with high CD44
and heterogeneous or loss of E-cadherin expressin and
group with low CD44 and regular E-cadherin expression.
Conclusions
The investigated molecular markers may be useful for the
prediction of outcomes and rate of recurrence in CRC
patients who have been operated on. In conjunction with
clinical and pathological staging, they may provide a stron-
ger indication of clinical outcomes than staging alone and
help improve selection of therapeutic options in CRC
patients.
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